Recent News About Williams & Connolly
View More
-
Three pharmacy companies targeted in the lawsuit had asked a judge to disqualify six out-of-state trial lawyers, over concerns they were wrongly using the IL attorney general to obtain information to help them in other lawsuits vs the same companies
-
SCOTUS ruling changed "approach" to drug labeling questions, plaintiffs said. GSK says the change wasn't "extraordinary" enough and would open "floodgates" to attempts at lawsuit "do-overs."
-
Judges said the jury award wasn't excessive, as woman claimed discontinued product left her with permanent injuries and pain.
-
The widow of a lawyer who took his own life, allegedly after taking the generic equivalent of widely prescribed antidepressant drug, Paxil, will not get a chance to undo a federal appeals court’s decision to toss out a federal jury’s findings that GSK, the maker of Paxil, owes her $3 million because it allegedly didn’t push federal regulators hard enough to revise the drug’s warning label.
-
The U.S. Supreme Court is tackling the question of whether drug companies can be sued for not making their warning labels strong enough, even though the FDA controls the labels. But whether a forthcoming Supreme Court decision will affect a decision denying a $3 million judgment to the widow of a Chicago lawyer who committed suicide after taking the generic equivalent of Paxil remains unclear.
